GIVE YOUR PATIENTS
Rapid Relief
FROM VAGINAL YEAST INFECTIONS
 
94% Clinical Cure Rate*
Gynazole1® (butoconazole nitrate) Vaginal Cream, 2%, indicated for vulvovaginal candidiaisis caused by all Candida species, has demonstrated 94% clinical efficacy against yeast infections. (1)
 
Extinguish Symptoms Fast†
Gynazole1 provides fast relief in just one dose. In fact, Gynazole1 showed a 77% greater decline vs miconazole nitrate, the active ingredient in Monistat® in severe yeast infection symptoms over 24 hours. (2)
 
Satisfied Patients Stay With
Gynazole1
In a survey of over 25,000 women, 97% said they would use Gynazole1 again. (1)
Gynazole-1® provides fast relief with just one dose.
 
One Anytime Dose and Less Mess for Increased Compliance (3,4)
Gynazole1's Site Release® bioadhesion mechanism is designed to adhere to living wet tissue for a targeted, continuous release of medication, making it the only single-dose cream that can be administered any time of the day or night. (2,5)
 
Managing the Risks of Patient Self-Diagnosis
Studies demonstrate that approximately two-thirds of women misdiagnose themselves as having a yeast infection and mistreat themselves with over-the-counter products. (6) Here are some ways you can help educate your patients on the importance of consulting you first.
Important Gynazole1 Information
  Please see full Prescribing Information
  Safety Information Footnote References
*Therapeutic efficacy is based on clinical cure rate (relief of symptoms) and microbiologic cure (pathogen eradication). The therapeutic efficacy rate after (30) days for the one-dose treatment (Gynazole1) was 62% as compared to 68% for the seven-day treatment (miconazole-7). The clinical cure rate for miconazole-7 at 8 to 10 days was 96%. Based on these results, there is no statistical difference between these treatments. (1,2)

†Within hours, Gynazole1 patients reported first signs of relief of one or more of the following symptoms: itching, burning, and irritation. Within approximately 24 hours, >75% of patients studied experienced the first signs of relief. (1)
Monistat® is a registered trademark of McNeil-PPC
 
 
 
Fast Relief
FOR LESS
Give your patients
$15 off their next prescription of
Gynazole1
QUICK FACTS
footnotes
Please view the
Gynazole1
Interactive Programs

to learn more about
The rapid relief of symptoms that Gynazole1 provides
The 94% efficacy of Gynazole1
Learn more about other Ther-Rx products
Anti-infectives
 - Clindesse®
Advanced Prescription
Nutritionals
 - Encora®
Prescription Prenatals
- PreCare Premier™
- PrimaCare®
- PrimaCare® ONE
- PremesisRx®
Iron Deficiency
 - Repliva 21/7 ™
 
 
Home    |    Search    |    Contact Us    |    Site Directory    |    Gynazole·1 Safety Information
Resource Library    |    Prescribing Information    |    Ther-Rx & Women's Healthcare



© 2008 Therx-Rx Corporation Terms of Use of Site